AbbVie, Inc. (ABBV)
262.82
+2.89
(+1.11%)
USD |
NYSE |
Oct 02, 16:00
263.85
+1.03
(+0.39%)
After-Hours: 20:00
AbbVie Max Drawdown (5Y) : 21.89% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 21.89% |
| August 31, 2026 | 21.89% |
| July 31, 2026 | 21.89% |
| June 30, 2026 | 21.89% |
| May 31, 2026 | 21.89% |
| April 30, 2026 | 21.89% |
| March 31, 2026 | 21.89% |
| February 28, 2026 | 21.89% |
| January 31, 2026 | 21.89% |
| December 31, 2025 | 21.89% |
| November 30, 2025 | 21.89% |
| October 31, 2025 | 21.89% |
| September 30, 2025 | 24.92% |
| August 31, 2025 | 24.92% |
| July 31, 2025 | 24.92% |
| June 30, 2025 | 24.92% |
| May 31, 2025 | 24.92% |
| April 30, 2025 | 25.56% |
| March 31, 2025 | 34.23% |
| February 28, 2025 | 42.18% |
| January 31, 2025 | 42.18% |
| December 31, 2024 | 42.18% |
| November 30, 2024 | 42.18% |
| October 31, 2024 | 42.18% |
| September 30, 2024 | 42.18% |
| Date | Value |
|---|---|
| August 31, 2024 | 42.97% |
| July 31, 2024 | 45.08% |
| June 30, 2024 | 45.08% |
| May 31, 2024 | 45.08% |
| April 30, 2024 | 45.08% |
| March 31, 2024 | 45.08% |
| February 29, 2024 | 45.08% |
| January 31, 2024 | 45.08% |
| December 31, 2023 | 45.08% |
| November 30, 2023 | 45.08% |
| October 31, 2023 | 45.08% |
| September 30, 2023 | 45.08% |
| August 31, 2023 | 45.08% |
| July 31, 2023 | 45.08% |
| June 30, 2023 | 45.08% |
| May 31, 2023 | 45.08% |
| April 30, 2023 | 45.08% |
| March 31, 2023 | 45.08% |
| February 28, 2023 | 45.08% |
| January 31, 2023 | 45.08% |
| December 31, 2022 | 45.08% |
| November 30, 2022 | 45.08% |
| October 31, 2022 | 45.08% |
| September 30, 2022 | 45.08% |
| August 31, 2022 | 45.08% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biogen, Inc. | 72.66% |
| Gilead Sciences, Inc. | 26.58% |
| Amgen, Inc. | 24.86% |
| Regeneron Pharmaceuticals, Inc. | 59.69% |
| Johnson & Johnson | 18.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 17.67 |
| Beta (5Y) | 0.2411 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 23.29% |
| Historical Sharpe Ratio (5Y) | 0.8623 |
| Historical Sortino (5Y) | 1.466 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 9.68% |